tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

United Therapeutics Corp

UTHR
Add to Watchlist
517.710USD
-8.110-1.54%
Close 07-31 16:00（ET）Quotes delayed by 15 min
21.82BMarket Cap
17.69P/E TTM

United Therapeutics Corp

517.710
-8.110-1.54%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

UTHR Financials

See United Therapeutics Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

United Therapeutics Corp Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/6.83
Revenue / Forecast
--/805.65M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
3.18B
10.61%
EPS(YoY)
30.13
13.95%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-11.93%6.32
25.09%8.39
11.58%7.73
9.56%6.86
10.00%7.18
45.58%6.71
21.46%6.93
13.33%6.26
25.38%6.52
60.86%4.61
--5.71
--5.53
--5.20
--2.87
--13.14
----
----
----
----
----
Revenue
-1.62%781.50M
7.38%790.20M
6.76%799.50M
11.71%798.60M
17.22%794.40M
19.72%735.90M
22.89%748.90M
19.85%714.90M
33.70%677.70M
25.07%614.70M
18.10%609.40M
27.76%596.50M
9.74%506.90M
18.38%491.50M
16.03%516.00M
4.57%466.90M
21.84%461.90M
7.87%415.20M
17.00%444.70M
23.34%446.50M
Net Profit
-14.68%274.90M
20.91%364.30M
9.58%338.70M
11.29%309.50M
5.09%322.20M
38.78%301.30M
15.51%309.10M
7.29%278.10M
27.27%306.60M
64.35%217.10M
11.83%267.60M
123.45%259.20M
0.42%240.90M
17.74%132.10M
47.08%239.30M
-32.79%116.00M
747.70%239.90M
13.56%112.20M
-4.96%162.70M
61.16%172.60M
Net Margin
-13.27%35.18%
12.60%46.10%
2.64%42.36%
-0.37%38.76%
-10.35%40.56%
15.93%40.94%
-6.01%41.27%
-10.48%38.90%
-4.80%45.24%
31.41%35.32%
--43.91%
--43.45%
--47.52%
--26.88%
--41.20%
----
----
----
----
----
Gross Margin
-6.14%82.93%
-3.09%86.91%
-1.71%87.38%
-0.10%89.03%
-0.99%88.36%
1.40%89.69%
0.46%88.90%
-0.15%89.12%
-0.49%89.24%
0.47%88.45%
--88.50%
--89.25%
--89.68%
--88.04%
--93.58%
----
----
----
----
----
Debt to assets ratio
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-100.00%0.00%
-72.04%2.58%
-58.29%4.07%
-50.70%5.62%
-37.89%7.44%
-26.72%9.24%
-26.20%9.77%
--11.39%
--11.97%
--12.61%
--13.24%
--13.84%
----
----
----
----
----
Income Statement
Revenue
-1.62%781.50M
7.38%790.20M
6.76%799.50M
11.71%798.60M
17.22%794.40M
19.72%735.90M
22.89%748.90M
19.85%714.90M
33.70%677.70M
25.07%614.70M
18.10%609.40M
27.76%596.50M
9.74%506.90M
18.38%491.50M
16.03%516.00M
4.57%466.90M
21.84%461.90M
7.87%415.20M
17.00%444.70M
23.34%446.50M
Operating profit
-14.89%325.80M
-1.70%357.50M
-4.63%389.30M
20.73%386.20M
7.44%382.80M
37.92%363.70M
24.83%408.20M
2.07%319.90M
25.28%356.30M
41.17%263.70M
4.04%327.00M
55.30%313.40M
-1.25%284.40M
9.37%186.80M
36.71%314.30M
-9.18%201.80M
339.02%288.00M
161.56%170.80M
3.98%229.90M
58.15%222.20M
Net Profit
-14.68%274.90M
20.91%364.30M
9.58%338.70M
11.29%309.50M
5.09%322.20M
38.78%301.30M
15.51%309.10M
7.29%278.10M
27.27%306.60M
64.35%217.10M
11.83%267.60M
123.45%259.20M
0.42%240.90M
17.74%132.10M
47.08%239.30M
-32.79%116.00M
747.70%239.90M
13.56%112.20M
-4.96%162.70M
61.16%172.60M
Balance Sheet
Current assets
-27.10%2.87B
-4.42%3.70B
-12.66%3.49B
5.73%3.83B
21.27%3.94B
9.09%3.87B
15.66%4.00B
12.64%3.62B
1.74%3.25B
5.05%3.55B
13.17%3.46B
19.71%3.21B
23.44%3.19B
45.48%3.38B
28.10%3.06B
15.81%2.68B
28.41%2.59B
7.22%2.32B
27.71%2.39B
22.36%2.32B
Total current liabilities
-16.96%599.10M
-24.05%560.60M
-37.45%546.30M
-36.67%527.10M
-16.16%721.50M
-8.24%738.10M
17.38%873.40M
124.76%832.30M
165.13%860.60M
134.38%804.40M
135.55%744.10M
11.70%370.30M
10.94%324.60M
12.38%343.20M
-1.28%315.90M
6.45%331.50M
-3.24%292.60M
-5.54%305.40M
23.60%320.00M
22.12%311.40M
Total assets
-13.30%6.71B
7.01%7.88B
3.20%7.35B
17.62%7.91B
19.22%7.74B
2.75%7.36B
1.42%7.12B
0.63%6.72B
2.35%6.50B
18.57%7.17B
21.48%7.02B
20.53%6.68B
18.40%6.35B
16.94%6.04B
14.51%5.78B
14.42%5.54B
15.49%5.36B
12.01%5.17B
14.46%5.05B
14.82%4.84B
Total liabilities
-13.20%813.10M
-14.80%783.80M
-25.56%760.90M
-28.42%734.40M
-19.05%936.70M
-22.18%920.00M
-22.06%1.02B
-19.23%1.03B
-5.37%1.16B
-5.26%1.18B
7.55%1.31B
3.71%1.27B
3.32%1.22B
3.11%1.25B
0.02%1.22B
1.62%1.22B
-1.01%1.18B
-0.79%1.21B
8.08%1.22B
7.08%1.21B
Total equity
-13.31%5.90B
10.12%7.10B
8.02%6.59B
25.91%7.17B
27.52%6.81B
7.67%6.44B
6.81%6.10B
5.29%5.70B
4.19%5.34B
24.77%5.98B
25.20%5.71B
25.30%5.41B
22.67%5.12B
21.16%4.80B
19.13%4.56B
18.65%4.32B
21.21%4.18B
16.60%3.96B
16.65%3.83B
17.64%3.64B
Cash Flow Statement
Net operating income
0.46%463.30M
1.47%346.20M
49.02%562.10M
-17.44%191.70M
22.50%461.20M
126.41%341.20M
8.95%377.20M
118.44%232.20M
0.45%376.50M
17.55%150.70M
33.87%346.20M
-16.30%106.30M
29.82%374.80M
-26.58%128.20M
39.33%258.60M
-14.30%127.00M
221.49%288.70M
38.35%174.60M
-26.03%185.60M
-9.63%148.20M
Net investment
551.55%743.70M
-84.74%-227.60M
222.63%140.90M
-274.88%-299.90M
-122.40%-164.70M
-392.64%-123.20M
63.34%-114.90M
64.79%-80.00M
432.56%735.30M
122.24%42.10M
-233.40%-313.40M
-34.44%-227.20M
38.45%-221.10M
3.32%-189.30M
60.15%-94.00M
-245.60%-169.00M
-5601.59%-359.20M
-206.90%-195.80M
13.18%-235.90M
86.97%-48.90M
Net financing
-1482.52%-1.48B
231.73%98.40M
-1391.42%-956.00M
-313.75%-198.60M
91.22%-93.80M
19.50%-74.70M
-943.42%-64.10M
-294.33%-48.00M
-2297.53%-1.07B
-267.21%-92.80M
8.57%7.60M
3.35%24.70M
541.82%48.60M
640.00%55.50M
-57.83%7.00M
125.47%23.90M
-208.91%-11.00M
22.95%7.50M
196.43%16.60M
-50.93%10.60M

FAQs

What is the total revenue of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its total revenue reached 3.18B, with a year-on-year change of 2.88B.

What are the current assets of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its current assets were 3.70B, with a year-on-year change of -4.42.

What are the total assets of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its total assets of United Therapeutics Corp were 7.88B, with a year-on-year change of 7.01.

What are the total liabilities of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its total liabilities of United Therapeutics Corp were 783.80M, with a year-on-year change of -14.80.

What is the total equity of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its total equity of United Therapeutics Corp was 7.10B, with a year-on-year change of 10.12.

What is the net operating income of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its net operating income of United Therapeutics Corp was 1.52B, with a year-on-year change of 4.77.

What is the net investment of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its net investment of United Therapeutics Corp was -551.30M, with a year-on-year change of -232.14.

What is the net financing of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its net financing of United Therapeutics Corp was -1.15B, with a year-on-year change of 8.35.

What is the Earnings Per Share (EPS) of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its Earnings Per Share (EPS) was 30.13, with a year-on-year change of 13.95.

What is the net income of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its net income was 1.33B, with a year-on-year change of 11.68.

What is the net margin of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its net profit margin was 41.94, with a year-on-year change of 0.97.

What is the gross margin of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its gross margin was 87.92, with a year-on-year change of -1.47.

What is the Return on Equity (ROE) of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its Return on Equity (ROE) was 19.71, with a year-on-year change of 2.51.

What is the Return on Assets (ROA) of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its Return on Assets (ROA) was 17.51, with a year-on-year change of 6.46.

What is the operating profit of United Therapeutics Corp?

According to United Therapeutics Corp's FY2025 earnings report, its operating profit was 1.52B, with a year-on-year change of 4.77.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy